Regulations.gov document
Q2(R2) Validation of Analytical Procedures and Q14 Analytical Procedure Development…
Notice · FDA-2022-D-1503 · posted Aug 29, 2022
Key facts
| Document ID | FDA-2022-D-1503-0001 |
|---|---|
| Title | Q2(R2) Validation of Analytical Procedures and Q14 Analytical Procedure Development; International Council for Harmonisation; Draft Guidances for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2022-D-1503 |
| Posted | Aug 29, 2022 |
| Federal Register citation | 87 FR 52784 |
| FR document number | 2022-18516 |
| Comment period opens | Aug 29, 2022 |
| Comments due | Sep 29, 2022 |
| Effective date | Aug 29, 2022 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: